🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
To determine the safety of the approach of giving RUXOLITINIB before and af...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02469974
Treatments Being Tested
The role of autologous stem cell transplantation (ASCT) in the first remiss...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2020-11-30
Trial ID
NCT04489264
Treatments Being Tested
First-line CAR-T-cell consolidation after an abbreviated induction with 2 c...
Status
Recruiting
Location
University Hospital of Mainz
Start Date
2024-02-15
Trial ID
NCT06482684
This is an investigator-initiated, open-label, single-arm, multicenter, Pha...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-15
Trial ID
NCT07387848
Treatments Being Tested
The purpose of this study is to improve overall survival while maintaining ...
Status
Completed
Location
Universitätskinderklinik Aachen
Start Date
2006-02-01
Trial ID
NCT00749723
The purpose of this study is to test whether regulatory T-cell reduction is...
Status
Completed
Location
University of Chicago
Start Date
2011-07-12
Trial ID
NCT01526096
In this research study, we are looking to explore the drug combination, len...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-09
Trial ID
NCT01208662
Treatments Being Tested
Specific somatic mutations using ctDNA will be analyzed in predefined subgr...
Status
Recruiting
Location
University Hospital Hradec Kralove
Start Date
2022-01-02
Trial ID
NCT06263530
This was a Phase 1, open-label, multicenter, study of checkpoint inhibitor ...
Status
Terminated
Location
Research Facility
Start Date
2016-12-13
Trial ID
NCT02716805
Treatments Being Tested